Single cell meta-analysis of EndMT and EMT state in COVID-19.

COVID-19 prognoses suggests that a proportion of patients develop fibrosis, but there is no evidence to indicate whether patients have progression of mesenchymal transition (MT) in the lungs. The role of MT during the COVID-19 pandemic remains poorly understood. Using single-cell RNA sequencing, we profiled the transcriptomes of cells from the lungs of healthy individuals (n = 45), COVID-19 patients (n = 58), and idiopathic pulmonary fibrosis (IPF) patients (n = 64) human lungs to map the entire MT change. This analysis enabled us to map all high-resolution matrix-producing cells and identify distinct subpopulations of endothelial cells (ECs) and epithelial cells as the primary cellular sources of MT clusters during COVID-19. For the first time, we have identied early and late subgroups of endothelial mesenchymal transition (EndMT) and epithelial-mesenchymal transition (EMT) using analysis of public databases for single-cell sequencing. We assessed epithelial subgroups by age, smoking status, and gender, and the data suggest that the proportional changes in EMT in COVID-19 are statistically significant. Further enumeration of early and late EMT suggests a correlation between invasive genes and COVID-19. Finally, EndMT is upregulated in COVID-19 patients and enriched for more inflammatory cytokines. Further, by classifying EndMT as early or late stages, we found that early EndMT was positively correlated with entry factors but this was not true for late EndMT. Exploring the MT state of may help to mitigate the fibrosis impact of SARS-CoV-2 infection.

Diabetic endothelial microangiopathy and pulmonary dysfunction.

Type 2 diabetes mellitus (T2DM) is a widespread metabolic condition with a high global morbidity and mortality rate that affects the whole body. Their primary consequences are mostly caused by the macrovascular and microvascular bed degradation brought on by metabolic, hemodynamic, and inflammatory variables. However, research in recent years has expanded the target organ in T2DM to include the lung. Inflammatory lung diseases also impose a severe financial burden on global healthcare. T2DM has long been recognized as a significant comorbidity that influences the course of various respiratory disorders and their disease progress. The pathogenesis of the glycemic metabolic problem and endothelial microangiopathy of the respiratory disorders have garnered more attention lately, indicating that the two ailments have a shared history. This review aims to outline the connection between T2DM related endothelial cell dysfunction and concomitant respiratory diseases, including Coronavirus disease 2019 (COVID-19), asthma, chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF).

Clinical characteristics of patients with SARS-CoV-2 Delta variant infection in Gansu Province

Objective: To summarize the clinical characteristics of patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant infection by comparing with patients with wild strain infection in Gansu Province. Methods: Totally 141 patients diagnosed with Delta variant infection(variant group)and 88 patients with COVID- 19 (wild strain group) in Gansu Province were selected, and their clinical data were retrospectively collected and compared. Results The proportion of patients with hypertension and vaccination was higher in the variant group than in the wild strain group (P < 0.05). Most of the two groups were mild and common types, and there were no statistically significant differences in the other general data (all P > 0.05). The percentages of fever, fatigue, muscle soreness, chest tightness and shortness of breath in the variant group were lower than those in the wild group, and the proportion of sore throat was higher than that in the wild group (all P < 0.05). The proportions of white blood cells (WBC) < 4.0 x 109/L, platelets (PLT) < 100x109/L, glutamyl transpeptidase (GGT) > 50.0 U/L, lactate dehydrogenase (LDH) > 240.0 U/L, blood urea nitrogen (BUN) > 7.1 mmol/L, and international normalized ratio (INR) >1.13 were all lower in the variant group than in the wild strain group (all P < 0.05);the percentage of aspartate aminotransferase (AST) > 40 U/L was higher than that of the wild strain group (P < 0.05). No significant differences were found in the alanine aminotransferase (ALT), blood creatinine (Cr), creatine kinase (CK), creatine kinase isoenzyme (CK-MB), activated partial thromboplastin time (APTT), prothrombin time (PT), calcitoninogen (PCT), or C-reactive protein (CRP) between these two groups (all P > 0.05). The proportions of abnormal chest CT, bilateral lesions, and three or more lobar lesions were significantly lower in the variant group than in the wild strain group (all P < 0.05). The proportions of treatments with interferon, ribavirin, lopinavir/ritonavir, antibiotics, glucocorticoids, immunoglobulins, hemopexin, Abidor tablets, and oxygen were lower in the variant group than in the wild strain group (all P < 0.05). The proportions of treatments with prone ventilation, anticoagulation, neutralizing antibodies, thymofacine, and hepatoprotective therapy were higher in the variant group than in the wild strain group (all P < 0.05). Thirty-five cases (53.0%) of lymphocytes in the wild strain group did not return to normal levels at discharge, and the differences in the time to recovery of lymphocytes, time to absorption of lung lesions, and time to nucle ic acid conversion between the two groups were not statistically significant (all P > 0.05). The recovery time of oxygen saturation (SaO2) in the variant group was shorter than that in the wild strain group, and the time of nucleic acid conversion and hospitalization was longer than that in the wild strain group (all P < 0.05). There were two deaths (2.3%) in the wild strain group and 0 death in the variant group, with no statistically significant difference between the two groups (P > 0.05). Conclusions: Compared with patients with wild strain infection, patients with Delta variant infection are mainly of light and common type with high vaccination coverage, smaller lung lesion involvement, shorter SaO2 recovery time, but longer nucleic acid regression time and hospitalization time, and have a good prognosis after oxygen therapy, traditional Chinese medicine, immune boosting, etc. The prognosis is good after conventional treatment.

Single cell meta-analysis of EndMT and EMT state in COVID-19

COVID-19 prognoses suggests that a proportion of patients develop fibrosis, but there is no evidence to indicate whether patients have progression of mesenchymal transition (MT) in the lungs. The role of MT during the COVID-19 pandemic remains poorly understood. Using single-cell RNA sequencing, we profiled the transcriptomes of cells from the lungs of healthy individuals (n = 45), COVID-19 patients (n = 58), and idiopathic pulmonary fibrosis (IPF) patients (n = 64) human lungs to map the entire MT change. This analysis enabled us to map all high-resolution matrix-producing cells and identify distinct subpopulations of endothelial cells (ECs) and epithelial cells as the primary cellular sources of MT clusters during COVID-19. For the first time, we have identied early and late subgroups of endothelial mesenchymal transition (EndMT) and epithelial-mesenchymal transition (EMT) using analysis of public databases for single-cell sequencing. We assessed epithelial subgroups by age, smoking status, and gender, and the data suggest that the proportional changes in EMT in COVID-19 are statistically significant. Further enumeration of early and late EMT suggests a correlation between invasive genes and COVID-19. Finally, EndMT is upregulated in COVID-19 patients and enriched for more inflammatory cytokines. Further, by classifying EndMT as early or late stages, we found that early EndMT was positively correlated with entry factors but this was not true for late EndMT. Exploring the MT state of may help to mitigate the fibrosis impact of SARS-CoV-2 infection.

Epidemiological and clinical characteristics of suspected COVID-19 patients in the isolation ward in Guangzhou, China: a cohort study.

BACKGROUND: Since there are reports of cases of 2019-coronavirus disease (COVID-19) asymptomatic carriers in China recently and fever is one of the main symptoms, we aimed to distinguish COVID-19 cases from other febrile patients with clinical examinations in this study. METHODS: A total of 134 suspected COVID-19 patients in the isolation ward of the First Affiliated Hospital of Guangzhou Medical University were recruited from January 23 to May 23, 2020. We analyze the pathogenic form and clinical characteristics. RESULTS: Among them, pathogens were identified in only 84 patients (62.7%), including 23 (17.1%) with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), 30 (22.3%) with other viruses, 31 (25.0%) with other pathogens and 3 (3.5%) with mixed infections. The commonly observed symptoms of COVID-19 patients were cough, fever, fatigue, and muscle aches, which were significantly different than the symptoms of nonviral infections (P<0.05) but from those of other viral infections (P>0.05). Furthermore, lactate dehydrogenase and the neutrophil/lymphocyte were found significantly high in COVID-19 patients compared to non-COVID-19 patients (P<0.05). The most common manifestations of COVID-19 patients were ground-glass opacities (100%) with or without lung consolidation, however, they also often showed involvement of several lobes of both lungs (P<0.05). Due to the clear differential diagnosis, the overall antibiotic use rate was 35.8% (31/87). CONCLUSIONS: When diagnosing COVID-19, infections with other pathogens should not be ignored. Successful pathogen identification will support accurate treatment.